Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study. [electronic resource]
Producer: 20070608Description: 1986-92 p. digitalISSN:- 1527-7755
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Chlorambucil -- administration & dosage
- Female
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Lymphoma, Follicular -- drug therapy
- Male
- Middle Aged
- Mitoxantrone -- administration & dosage
- Prednisolone -- administration & dosage
- Prognosis
- Recombinant Proteins
- Rituximab
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.